Stocks · Health care · Pharmaceutical Preparations

Verastem, Inc.

VSTM Clue Score56
United States Fiscal year ends December CIK 0001526119 Results filed 14 Oct 2026

What the insiders did Scheduled selling only

By person

13 insiders · 32 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Dan Paterson
President and CEO
—
$835.41K (22) scheduled
−$835.41K
651,413
0.7193%
$6.25M
−18.1%
Michael Kauffman
President of Development
—
$85.50K (1) scheduled
−$85.50K
8,666
0.0096%
$83.19K
−2.4%
Daniel Calkins
Chief Financial Officer
—
$74.75K (6) scheduled
−$74.75K
123,781
0.1367%
$1.19M
−13.4%
Paul A. Bunn
Director
—
$62.50K (1) scheduled
−$62.50K
44,333
0.0490%
$425.60K
+432.0%
Brian M Stuglik
Director
—
$5.41K (1) scheduled
−$5.41K
137,147
0.1514%
$1.32M
+42.7%
Robert E. Gagnon
Director
—
$2.59K (1) scheduled
−$2.59K
41,678
0.0460%
$400.11K
+19.4%
Michael P Bailey
Director
—
—
—
108,000
0.1193%
$1.04M
—
Eric K Rowinsky
Director
—
—
—
52,666
0.0582%
$505.59K
+532.0%
Anil Kapur
Director
—
—
—
52,666
0.0582%
$505.59K
+532.0%
John Johnson
Director
—
—
—
52,666
0.0582%
$505.59K
+532.0%
Michelle Robertson
Director
—
—
—
52,666
0.0582%
$505.59K
+532.0%
Karin Anna Tollefson
Director
—
—
—
52,666
0.0582%
$505.59K
+532.0%
Matthew Ros
Chief Operating Officer
—
—
—
50,000
0.0552%
$480.00K
—